电子邮件 | ams***@***.ca | 获取Email |
---|
电子邮件 | ams***@***.ca | 获取Email |
---|
CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines against future epidemics. Prior to COVID-19, CEPI's work focused on developing vaccines against the Ebola Virus Disease, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever virus and Chikungunya virus. It has over 20 vaccine candidates against these pathogens in development. CEPI has also invested in new platform technologies for rapid vaccine development against unknown pathogens (Disease X). During the current pandemic, CEPI initiated multiple programmes to develop vaccines against SARS-CoV-2 and its variants with a focus on speed, scale, and access. These programmes leverage the rapid response platforms developed by CEPI's partners prior to the emergence of COVID-19, as well as new collaborations. The aim is to advance clinical development of a diverse portfolio of safe and effective COVID-19 candidates and to enable fair allocation of these vaccines worldwide through COVAX. CEPI's 5-year plan lays out a $3.5 billion roadmap to compress vaccine development timelines to 100 days, develop a broadly protective vaccine against COVID-19 and other Betacoronaviruses, and create a "library" of vaccine candidates for use against known and unknown pathogens. The plan is available at www.endpandemics.cepi.net
公司 | CEPI (Coalition for Epidemic Preparedness Innovations) |
---|---|
职位 | Project Leader |
地点 | Canada |
http://www.linkedin.com/in/ann-muriel-steff-49a35b9 | |
部门 | master_information_technology |
头衔 | Project Leader - Disease X - CEPI (Coalition for Epidemic Preparedness Innovations) |
CEPI (Coalition for Epidemic Preparedness Innovations) Project Leader
2023-01-01 -
GSK Head Preclinical R&D - GSK Rockville Center for Vaccine Research
2021-05-01 - 2023-01-01
GSK Director, Discovery Project Leader, Vaccines
2016-05-01 - 2021-05-01
GSK Head, Preclinical R&D North America, Vaccines
2014-08-01 - 2016-05-01
Charles River Laboratories Senior Research Scientist, Pharmacokinetics
2008-01-01 - 2011-01-01
Ann-Muriel Steff 在 CEPI (Coalition for Epidemic Preparedness Innovations) 担任 Project Leader - Disease X - CEPI (Coalition for Epidemic Preparedness Innovations)
Ann-Muriel Steff 在 CEPI (Coalition for Epidemic Preparedness Innovations) 的职位是 Project Leader - Disease X - CEPI (Coalition for Epidemic Preparedness Innovations)
Ann-Muriel Steff 的电子邮件地址是 ams***@***.ca
Ann-Muriel Steff 的电话号码是 -
Ann-Muriel Steff 的公司电话号码是 -
Ann-Muriel Steff 在 research 工作。
Ann-Muriel Steff 的一些同事包括Ann-Muriel Steff、Selgun Ozker、Emmanuelle Espie、Maria IacovoneSheldon Poujade、。
Ann-Muriel Steff联系方式: 电子邮件地址:ams***@***.ca 电话号码:-
Ann-Muriel Steff 的个人领英是:http://www.linkedin.com/in/ann-muriel-steff-49a35b9
Ann-Muriel Steff 的办公地点:marcus thranes gate 2, oslo, norway, 0473
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd